20 May 2013
Keywords: blow, akzo, nobel, fda, asks, data, ariza
Article | 22 April 2002
Dutch chemical and pharmaceutical group Akzo Nobel has said that it willbe unable to launch its new antidepressant drug Ariza ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 April 2002
© 2013 thepharmaletter.com